C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 14, 2005

Primary Completion Date

August 22, 2007

Study Completion Date

August 22, 2007

Conditions
Hereditary Angioedema
Interventions
BIOLOGICAL

C1 esterase inhibitor [human] (C1INH-nf)

DRUG

Placebo (saline)

Trial Locations (16)

10029

Mount Sinai School of Medicine, New York

20902

Institute for Asthma and Allergy, Wheaton

26101

St. Joseph's Hospital/Cornerstone Healthcare, Parkersburg

30024

Atlanta Allergy and Asthma Clinic, Suwanee

43205

Nationwide Childrens Hospital Clinical Research, Columbus

47713

Welborn Clinic Allergy and Immunology, Evansville

59923

Libby Clinic, Libby

70601

Lake Charles Memorial Hospital, Lake Charles

74133

Allergy Clinic of Tulsa, Tulsa

75231

AARA Research Center, Dallas

75979

Tyler County Hospital, Woodville

85251

Allergy and Immunology Associates, Scottsdale

94598

Allergy and Asthma Clinical Research, Inc, Walnut Creek

96826

Hawaii Pacific Health Research Institute, Honolulu

97035

Allergy Asthma and Dermatology Research Center, Lake Oswego

92093-0732

University of California, San Diego, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY